Defibrillator Market Report by Product, End-User, Countries, and Company Analysis 2026-2034

Defibrillator Market Size and Forecast 2026-2034

The international defibrillator market is likely to register steady growth during the forecast period, owing to the increasing incidence of cardiovascular diseases, rising awareness about sudden cardiac arrest, and the increasing use of automated external defibrillators in public and healthcare settings. Technological advancements and government support are also key factors that contribute to the growth of the market. The market is likely to grow from US$ 6.11 Billion in 2025 to US$ 9.68 Billion in 2034, registering a Compound Annual Growth Rate of 5.25% from 2026 to 2034.

Defibrillator Market Overview

A defibrillator is a medical device that is employed to return the heart to its normal rhythm in cases where the heart is experiencing life-threatening rhythms, such as ventricular fibrillation or cardiac arrest. The device functions by applying an electric shock to the heart, which enables the heart to return to its normal rhythm. Defibrillators are normally used in hospitals and emergency services, and they also consist of portable devices like automated external defibrillators, which are used by laypeople. Implantable cardioverter defibrillators are employed in patients who are at a high risk of experiencing cardiac events.

Defibrillators have become extremely popular across the globe due to the increasing number of cases of cardiovascular diseases and the awareness of sudden cardiac arrest. Governments and health institutions are encouraging the installation of AEDs in public areas such as airports, schools, offices, and shopping malls. Defibrillators have become smaller, easier to operate, and more reliable due to advancements in technology. With the increasing awareness of emergency preparedness and health, defibrillators have become a crucial tool for saving lives across the globe.

Growth Drivers of the Global Defibrillators Market

Rising Prevalence of Cardiovascular Diseases

One of the main driving forces for the growth of the global defibrillators market is the rising incidence of cardiovascular diseases across the world. Coronary artery disease, arrhythmias, and sudden cardiac death are becoming more prevalent due to the rising average age of the population, a sedentary lifestyle, obesity, and stress. These diseases increase the risk of sudden cardiac death, which is a life-threatening situation that requires immediate defibrillation. As the healthcare infrastructure shifts its focus to improving emergency cardiac care and lowering mortality rates, the demand for defibrillators in hospitals, ambulances, and emergency cardiac care units is increasing steadily. Rising screening and diagnosis of heart diseases also contribute to the rising demand for implantable and external defibrillators, thus fueling the growth of the market across the globe. About 80% of the world's deaths due to CVDs occur in low- and middle-income countries. People in low- and middle-income countries do not have access to primary health care programs for early detection and treatment of individuals with risk factors for CVDs.

Expanding Deployment of Automated External Defibrillators

The increasing use of automated external defibrillators in public and private settings is a key driving factor for the defibrillators market. Governments and medical institutions are encouraging public access defibrillation programs to enhance survival rates for sudden cardiac arrest. AEDs are being installed in greater numbers in airports, schools, offices, shopping malls, and sports stadiums. Their ease of use enables laypeople to offer life-saving support during emergencies. Public health awareness of emergency preparedness is increasing, and mandatory AED installation policies in certain countries are further fueling adoption. As a result, demand for AEDs is increasing steadily across the globe. March 2024, Stryker has launched and demonstrated two new products: "LIFEPAK CR2 automated external defibrillator (AED) for cardiac care" and "Evacuation Chair" for emergency patient evacuation.

Technological Advancements and Product Innovation

The defibrillators market is being fueled by technological advancements. Technological advancements include the development of lightweight and portable defibrillators, advancements in battery life, real-time monitoring, and connectivity options. The latest defibrillators are equipped with advanced algorithms that enable the accurate analysis of heart rhythms and the administration of corresponding therapy. The development of smart and connected defibrillators that can be connected to hospital information systems enhances patient monitoring and data management. With advancements in technology, the defibrillators market is expected to register steady growth. March 2025 - Medtronic Japan Co., Ltd. announced that the Aurora EV-ICDTM MRI system and the Epsila EVTM MRI Lead, used in the management of ventricular arrhythmias, were launched one after the other in the Japanese market.

Key Challenges of the Global Defibrillators Market

High Cost of Devices and Limited Accessibility

One of the biggest challenges in the defibrillators market is the high cost that comes with the development of advanced defibrillator technology. Implantable cardioverter defibrillators and advanced external defibrillators require the use of costly components, complex manufacturing processes, and specialized installation and maintenance. The high cost of these technologies may serve as a barrier to adoption, especially in developing countries and smaller healthcare settings. Even public access programs for AEDs require substantial investment in procurement, training, and maintenance. The lack of reimbursement coverage in some areas further serves as a barrier to access.

Lack of Awareness and Training Among the General Public

Another major challenge for the defibrillators market is the absence of awareness and training among the general public. Even though AEDs are intended for use by non-medical professionals, many people are reluctant to use them because they are afraid of making errors or being held liable. There is a lack of awareness and training among the general public, which makes it difficult to make effective use of the devices in emergency situations. A lack of awareness about the location and functioning of AEDs can cause delays in emergency situations.

Implantable Defibrillators Market

The market for implantable defibrillators is fueled by the increasing incidence of life-threatening cardiac arrhythmias and sudden cardiac death in high-risk patients. An implantable cardioverter defibrillator (ICD) is a surgically implanted device that continuously monitors the heart rhythm and provides corrective electrical shocks when irregularities are detected. The device is often prescribed to patients who have had previous episodes of heart failure. Advances in technology, including miniaturization of the device, increased battery life, and enhanced sensing algorithms, have improved patient comfort and efficacy. The increasing awareness of cardiologists and advances in diagnostic capabilities continue to fuel the market. The rising incidence of cardiovascular diseases worldwide fuels the demand for implantable defibrillators.

External Defibrillators Market

The external defibrillators market comprises manual defibrillators and automated external defibrillators. These are used in hospitals, ambulances, and public areas. The use of AEDs in public areas and emergency medical services is a key factor driving the market. The development of user-friendly devices with voice guidance and portability has increased their use. The development of emergency care infrastructure and public health programs is also a supporting factor. External defibrillators are an important tool for saving lives in public areas.

Defibrillators Hospital Market

The hospitals are a significant end-user segment of the defibrillators market. The defibrillators are a crucial part of the emergency care department, intensive care unit, and operation theaters. The hospitals need advanced and reliable defibrillators to monitor patients continuously. The rising number of hospital admissions due to cardiovascular diseases is a significant factor in the growing demand for defibrillators. The integration of defibrillators with the hospital information system is improving patient data management.

Defibrillators Home Healthcare Market

The home healthcare market for defibrillators is growing due to an increasing number of patients being treated for cardiac ailments outside the hospital setting. Portable and wearable defibrillators are being increasingly used by patients at risk of sudden cardiac arrest. These devices provide continuous monitoring and instant response, which improves patient safety and freedom. The rising preference for home-based healthcare and the aging population are factors that contribute to the growth of the market.

Defibrillators Public Access Market

The market for defibrillators in the public access segment is fueled by efforts to enhance survival rates due to sudden cardiac arrest in public settings. Automated external defibrillators are being placed in airports, schools, offices, shopping malls, and sports stadiums. Public access defibrillation initiatives focus on quick action and public participation. Easy-to-use devices and greater awareness campaigns contribute to this end. With emergency preparedness being a worldwide concern, the public access defibrillators market is steadily growing.

United States Defibrillators Market

The United States defibrillators market is one of the largest in the world, due to the high incidence of cardiovascular diseases and an advanced healthcare infrastructure. The adoption of automated external defibrillators in public areas, organizations, and institutions of learning also contributes to the growth of the market. The use of advanced manual and implantable defibrillators in hospitals and emergency medical services also drives the market. Favorable government reimbursement policies and increased awareness of sudden cardiac arrest also stimulate the market. Continuous innovation and the presence of major players in the US market also enhance the market. With the expansion of public access defibrillation programs, the demand for defibrillators also remains high. In January 2026, Medtronic has commercially launched the OmniaSecure defibrillation lead in the USA this week, with the first cases being performed at hospitals across the country.

United Kingdom Defibrillators Market

The United Kingdom defibrillators market is fueled by government-backed programs encouraging public access defibrillation and emergency readiness. The massive deployment of AEDs in public locations like transportation centers, sports arenas, and community centers helps fuel the market. Hospitals require advanced defibrillators for emergency and critical care. Increasing knowledge about cardiovascular health and better training programs make a positive impact. With the UK improving its emergency response infrastructure, the use of defibrillators is steadily on the rise. October 2025, St John Ambulance are delighted to announce that we have launched our own-brand defibrillator to help save lives across the nation. As part of the launch, a competition was held to name the new life-saving device. The winner was Robin, a Badger from the South-East Hampshire Network, who was chosen as the overall winner.

India Defibrillators Market

The India defibrillators market is a developing one, and it is supported by the growing awareness of cardiac health and the development of the healthcare infrastructure. The rising number of cases of heart disease and sudden cardiac arrest is driving the demand for defibrillators in hospitals and ambulances. Public access defibrillation is still in its infancy but is slowly increasing in urban areas. The rising investment in the development of healthcare infrastructure and emergency services is supporting the growth of the market. Although the challenges of affordability and awareness are present, the growing use of AEDs and portable defibrillators is supporting the steady growth of the market. March 2023, The Telangana government will be buying 1200 Automatic External Defibrillator (AED) devices for ₹18 crore, which will be installed in all Primary Health Centres, UPHCs, and Basthi Dawakhanas in a month, said the Health Minister.

Saudi Arabia Defibrillators Market

The Saudi Arabia defibrillators market is driven by increasing investments in the healthcare sector and the rising emphasis on emergency medical services. Hospitals and healthcare centers use advanced defibrillators to treat cardiac emergencies. Public access defibrillation is gradually increasing in urban and busy areas. Government efforts to enhance the quality of healthcare and emergency readiness contribute to the growth of the market. Rising awareness about sudden cardiac arrest drives the demand for defibrillators in the Saudi Arabia market. In April 2023, the Saudi Red Crescent Authority (SRCA) began the installation of Automated External Defibrillators (AEDs) in the mosques of the Riyadh region. The first of these devices has been installed in the Mamur Mosque in the Qurtubah district in Riyadh, which falls within a number of initiatives launched by the authority.

Market Segmentation

Product

• Implantable Defibrillators
• External Defibrillators

End-Users

• Hospital
• Pre-hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

Country

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All the Key players have been covered from 3 Viewpoints:

• Overview
• Recent Developments
• Revenue Analysis

Company Analysis:

• Medtronic Plc
• Boston Scientific Corporation
• Philips Healthcare
• Nihon Kohden Corporation
• Asahi Kasei Corporation
• Stryker Corporation
• Abbott
• LivaNova PLC